Skip to main content
Top
Published in: Acta Diabetologica 8/2023

Open Access 28-04-2023 | Escherichia Coli | Original Article

Gut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum

Authors: Noora Houttu, Chouaib Benchraka, Mrunalini Lotankar, Ella Muhli, Harri Niinikoski, Leo Lahti, Kirsi Laitinen

Published in: Acta Diabetologica | Issue 8/2023

Login to get access

Abstract

Aims

Deep metagenomics offers an advanced tool for examining the relationship between gut microbiota composition and function and the onset of disease; in this case, does the composition and function of gut microbiota during pregnancy differ in women who develop prediabetes and those who do not at two-year postpartum, and whether the gut microbiota composition associates with glycemic traits.

Methods

In total, 439 women were recruited in early pregnancy. Gut microbiota was assessed by metagenomics analysis in early (13.9 ± 2.0 gestational weeks) and late pregnancy (35.1 ± 1.0 gestational weeks). Prediabetes was determined using American Diabetes Association criteria as fasting plasma glucose 5.6–6.9 mmol/l analyzed by an enzymatic hexokinase method. Of the women, 39 (22.1%) developed prediabetes by two-year postpartum.

Results

The relative abundances of Escherichia unclassified (FDR < 0.05), Clostridiales bacterium 1_7_ 47FAA (FDR < 0.25) and Parabacteroides (FDR < 0.25) were higher, and those of Ruminococcaceae bacterium D16 (FDR < 0.25), Anaerotruncus unclassified (FDR < 0.25) and Ruminococcaceae noname (FDR < 0.25) were lower in early pregnancy in those women who later developed prediabetes. In late pregnancy, Porphyromonas was higher and Ruminococcus sp 5_1_39BFAA was lower in prediabetes (FDR < 0.25). Furthermore, fasting glucose concentrations associated inversely with Anaerotruncus unclassified in early pregnancy and directly with Ruminococcus sp 5_1_39BFAA in late pregnancy (FDR < 0.25). α-Diversity or β-diversity did not differ significantly between the groups. Predictions of community function during pregnancy were not associated with prediabetes.

Conclusions

Our study shows that some bacterial species during pregnancy contributed to the onset of prediabetes within two-year postpartum. These were attributable primarily to a lower abundance of short-chain fatty acids-producing bacteria.
Appendix
Available only for authorised users
Literature
14.
go back to reference Pellonperä O, Mokkala K, Houttu N, et al. (2019) Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: a randomized, placebo-controlled. Double-Blind Clin Trial Diabetes care 42(6):1009–1017. https://doi.org/10.2337/dc18-2591CrossRef Pellonperä O, Mokkala K, Houttu N, et al. (2019) Efficacy of fish oil and/or probiotic intervention on the incidence of gestational diabetes mellitus in an at-risk group of overweight and obese women: a randomized, placebo-controlled. Double-Blind Clin Trial Diabetes care 42(6):1009–1017. https://​doi.​org/​10.​2337/​dc18-2591CrossRef
16.
go back to reference Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed
24.
go back to reference Wright MN, Ziegler A (2017) Ranger: a fast implementation of random forests for high dimensional data in C++ and R. J Stat Softw 77:1–17CrossRef Wright MN, Ziegler A (2017) Ranger: a fast implementation of random forests for high dimensional data in C++ and R. J Stat Softw 77:1–17CrossRef
Metadata
Title
Gut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum
Authors
Noora Houttu
Chouaib Benchraka
Mrunalini Lotankar
Ella Muhli
Harri Niinikoski
Leo Lahti
Kirsi Laitinen
Publication date
28-04-2023
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 8/2023
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-023-02064-5

Other articles of this Issue 8/2023

Acta Diabetologica 8/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.